Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jianhui Pharmaceutical Co., Ltd. is a comprehensive Chinese pharmaceutical enterprise specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a leading global producer of lincosamide antibiotics, including clindamycin and lincomycin derivatives, and operates manufacturing facilities that adhere to international GMP standards. In addition to its core anti-infective portfolio, Jianhui Pharmaceutical develops and markets a variety of chemical drugs targeting cardiovascular and gastrointestinal conditions. Founded and led by Jianhui Gan, the company serves as a critical supplier in the global pharmaceutical supply chain, providing high-quality products to both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jianhui Gan.